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Abstract: Active alkaline phosphatase of Escherichia coli (PhoA, EC 3.1.3.1) was displayed via the leucine zipper ele-
ment of the Jun-Fos heterodimer on the surface of filamentous phage and the kinetic parameters Km and kcat were deter-
mined. The phoA gene was cloned downstream of fos while jun was inserted upstream of pIII or pVIII, alternatively, in the 
pJuFo phagemid vector. Both fusion genes are regulated by independent lacZ promoters. PhoA displayed on the phagemid 
pIII surface exhibited a Km of 11.2 M with 4-nitrophenyl phosphate as substrate, which is consistent with data published 
for soluble PhoA. Based on these data we calculated the decoration of pJuFo phagemid with PhoA using the minor and 
major coat proteins pIII and pVIII as fusion partners under variable inducing conditions. We found that, even if the pro-
moters are fully induced at a concentration of 1000 M IPTG, the phagemids display maximally one copy of PhoA-Fos-
Jun-coat protein fusion, irrespective of whether the protein is presented via pIII or pVIII. However, since PhoA is dis-
played in a native-like fashion, as deduced from the kinetic parameters of the enzymatic reaction, the pJuFo technology 
provides a versatile tool for the functional screening of complex cDNA libraries displayed on the phagemids' surface. 
INTRODUCTION 
  Most functional proteomic approaches aim at the identi-
fication of interactions between naturally occurring proteins. 
Once the interactions are known the resulting interactome 
networks can provide information about complex molecular 
interactions and improve our understanding of evolutionary, 
metabolic, molecular and cellular processes [1]. Recently, 
enhanced modifications of the original yeast two-hybrid sys-
tem [2] have been used to generate entire interaction maps of 
the yeast Saccharomyces cerevisiae [3, 4] and the nematode 
worm Caenorhabditis elegans [5]. The problem of relatively 
frequent false-positive hints remains a major disadvantage of 
this in vivo technology [6]. As an alternative, lambda phage 
based screening or phage surface display of cDNA libraries 
are often favoured over the two-hybrid system, if a library 
needs to be screened against an immobilized monoclonal or 
oligoclonal ligand because both in vitro screening systems 
allow variation of the binding conditions. 
  Phage display differs from other screening systems be-
cause molecular libraries incorporated into the phage ge-
nome are expressed on the surface of phage particles [7]. The 
physical linkage between genotype and phenotype allows 
maintaining a phage library in the liquid phase and therefore 
efficient screening based on the power of affinity selection. 
cDNA phage display systems based on bacteriophages T7 [8, 
9], lambda [10], and filamentous phage [11-15] have been 
recently reported and reviewed elsewhere [16, 17]. 
  Among the filamentous phage display approaches the 
pJuFo technology, which is based on an indirect fusion ap-
proach to display products on the surface of helper phage  
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assisted phagemid assemblies, has widely been used for the 
surface expression of cDNA libraries, and yielded complex 
allergen repertoires of various allergenic sources [18]. Fur-
thermore, the technology provided a valuable tool for the 
identification of tumor-associated antigens [19], self-
antigens [20] or epitopes of polyclonal antibody sera [21]. 
Since the applications of this methodology are quite diverse, 
and yet it has not met substantial limitations, we investigated 
the efficiency of the pJuFo surface presentation choosing E. 
coli alkaline phosphatase (PhoA, EC 3.1.3.1) as a model 
system. PhoA was cloned adjacent to fos of the pJuFo vector 
and expressed as a Jun-Fos-pIII or Jun-Fos-pVIII fusion pro-
tein on the phagemids' surface (Fig. 1). Under reaction con-
ditions in which PhoA exhibits Michaelis-Menten behaviour 
we obtained the kinetic parameters Km and kcat of phagemid-
displayed PhoA. Comparison of these kinetic parameters 
with those of wild-type PhoA allowed calculating the deco-
ration of phagemid with functional PhoA fusion proteins. 
MATERIALS AND METHODS  
Construction of pJuFoVIII::phoA 
  Production of phage displaying PhoA of E. coli as a pIII 
fusion protein by means of the Jun-Fos linker is described 
elsewhere [11, 37]. For the construction of a pVIII-display 
pJuFo vector, the DNA encoding pVIII was amplified by 
PCR using M13K07 helper phage as a template and the fol-
lowing oligonucleotides: 5'-primer pVIII: 5'-ACG GGA 
TCC GGT GGC GGT GGC TCT GCT GAG GGT GAC-3', 
3'-primer pVIII: 5'-GTG TTA CTA GCT AGC TTT AAT 
TGT ATC GGT TTA-3'. The PCR fragment was hydrolysed 
with BamHI and NheI, gel purified and used to replace the 
BamHI-NheI fragment in pJuFo. The ligation mixture was 
used to transform E. coli XL1-Blue (Stratagene, La Jolla, 
CA, USA) electrocompetent cells [38] which were then 
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g/ml tetracycline (LB/Amp+Tc). Single colonies were 
picked and grown. DNA was prepared and the final construct 
was was verified by restriction analysis and DNA sequenc-
ing (Microsynth, Balgach, Switzerland). The pJuFoVIII:: 
phoA phagemid was constructed by XbaI+KpnI hydrolysis 
of the pJuFoVIII vector and ligation with correspondingly 
hydrolysed phoA DNA derived from pJuFoIII::phoA [11]. 
Preparation of PhoA-Phagemids 
  110-150 ml 2YT medium with 100 g/ml ampicillin 
and 10 g/ml tetracycline (2YT/Amp+Tc) were inoculated 
1:50 with a stationary culture of E. coli XL1-
Blue/pJuFo::phoA or XL1-Blue/pJuFoVIII::phoA and incu-
bated at 37°C and 250 rpm until an OD550 of  0.5 was 
reached. Then helper phage VCS-M13 (Stratagene) was 
added at a multiplicity of infection (moi) of 10 and the cul-
ture was incubated for 30 min at 30°C, 150 rpm. After 30 
min agitation of the culture was raised to 300 rpm and the 
culture was incubated for additional 9.5 h at 30°C. 2 h after 
infection with helper phage, kanamycin (kan) was added to a 
concentration of 70 g/ml. For experiments, in which the 
decoration of phage with PhoA was determined in depend-
ence of the inducer concentration, IPTG was added 30 min 
after infection with helper phage. 
  PhoA-phagemid containing supernatant was prepared 10 
h after helper phage addition by centrifugation (4'500  g, 
4°C, 15 min) and PhoA-phagemid was precipitated by addi-
tion of  volume 25% (w/v) polyethylene glycol (MW: 
8'000), 15% (w/v) NaCl at 4°C for 20 min. After centrifuga-
tion (15'000  g, 4°C, 20 min) the supernatant was removed 
and the precipitated phagemid was dissolved in 10 mM 
Tris/HCl pH 8.0 (4 vol. % of the original supernatant vol-
ume). After centrifugation (15'000   g, 4°C, 10 min) the 
cleared solution was transferred into fresh tubes and PhoA-
phagemid was precipitated again with PEG/NaCl as de-
scribed above, the supernatant was removed quantitatively 
and precipitated PhoA-phagemid was dissolved in 10 mM 
Tris/HCl pH 8.0 (4 vol. % of the original supernatant vol-
ume). After final centrifugation (15'000  g, 4°C, 10 min) 
the PhoA-phagemid solution was transferred into new tubes, 
kept at 4°C and readily used for the determination of infec-
tivity and for enzymatic assays. Samples immediately not 
used for experiments were stored at -20°C directly after 
preparation. 
Inducibility of pJuFoIII::phoA and pJuFoVIII::phoA 
  To test the inducibility of the phagemid vectors by IPTG 
after addition of helper phage we prepared periplasmic ex-
tracts of XL1-Blue using a moderately modified protocol for 
cold osmotic shock [39]: portions of 25 ml were taken from 
a 200 ml PhoA-phagemid producing XL1-Blue culture at 
distinct times after VCS-M13 superinfection and centrifuged 
(4'500    g, 4°C, 15 min). The supernatant was removed 
completely and bacterial pellets washed by gentle re-
suspension in 1 ml of 2YT followed by centrifugation 
(4'500  g, 4°C, 15 min). After medium removal the bacteria 
were resuspended in 1 ml 500 mM Saccharose, 100 mM 
Tris/HCl, 1 mM EDTA pH 8.0 and incubated on ice for 30 
min in the presence of 100 g/ml hen egg white lysozyme 
(Roche, Basel, Switzerland). The spheroplasts were sedi-
mented (15'000  g, 4°C, 15 min) and the periplasmic frac-
tions were stored at -20°C. 
Western Blots 
  Western blot analysis was used to detect wild-type (wt) 
PhoA (Sigma, St. Louis, MO, USA) or Fos-PhoA in the pe-
riplasmic fractions as well as in the phagemid preparations. 
Therefore, samples were subjected to SDS-PAGE (Nu-
PAGE
™, 12% Bis-Tris, Invitrogen
™) and electrotransferred 
onto a Hybond
™-P PVDF membrane (Amersham Pharmacia 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Genetic elements of the pJuFo vector and proposed mechanism for the assembly of PhoA-phagemids. In the present work PhoA was 
displayed either as pIII or pVIII fusion protein via the heterodimeric Jun-Fos linker on the surface of filamentous phagemid. 
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Biotech, Uppsala, Sweden). Free binding sites were blocked 
with 5% non-fat dried milk, 0.1 % (v/v) Tween-20 in TBS. 
PhoA was detected with horse radish peroxidase labelled 
rabbit polyclonal anti-bacterial AP mAb 7319 (1:10'000 in 
blocking buffer, Abcam, Cambridge, United Kingdom) and 
visualised by chemiluminescence (ECL
™, Amersham Phar-
macia Biotech) substrate. 
Enzymatic Assays 
  PhoA-phagemid enzyme activity was assayed basically 
as described by McCafferty et al. [31]. Briefly, reactions 
were initiated by adding 50 l PhoA-phagemid solution to 
950 l of 4-nitrophenyl phosphate (Fluka, Buchs, Switzer-
land) at a range of concentrations in 1.052 M Tris/HCl pH 
8.0. The initial rates were calculated from the change of the 
absorbance at 410 nm in the first 6 s of each reaction at 25°C 
using a molar absorption coefficient of 16'200 M
-1 cm
-1 [40]. 
The concentration of PhoA-phagemid was determined by 
preparing ssDNA using phenol/chloroform/ isopropanol ex-
traction, ethanol precipitation and measuring at 260 nm. The 
A260/A280 ratio of the ssDNA prepared this way was always 
higher than 1.77. The molar absorption coefficients of the 
individual single stranded vector contructs were calculated 
with the Omiga 2.0 software (Oxford Molecular, Oxford, 
England). Purified E. coli PhoA was purchased from Sigma. 
The concentration was calculated by measuring the absor-
bance at 278 nm [41] using a Mr of 47'029 per subunit [28]. 
The kinetic parameters Km and kcat were derived fromnonlin-
ear least-square fits according to the Michaelis-Menten 
model. For practical reasons kcat values are expressed as mo-
lar activities (mol. act.) and specified in mol substrate/mol 
phage (or enzyme)/min throughout this paper. All absorption 
measurements were performed on an Uvikon XL spectro-
photometer (Bio-Tek Instruments, Winooski, VT, USA). 
Phagemid Infectivity 
  Infectivity is defined as the ratio between infective and 
total phage. Total phagemid was measured by preparing 
ssDNA as described above, infective phagemid was deter-
mined by infecting exponentially growing E. coli XL1-Blue 
with three independent dilution series of each phagemid 
preparation and plating out on LB/Amp+Tc agar. 
RESULTS  
Kinetic Properties of PhoA Displayed on the Surface of 
pJuFo Phagemids 
  Display of cDNA libraries on the surface of filamentous 
phage and their screening for interacting proteins against 
immobilized targets still remains a challenge in proteomics. 
Although also pVI as fusion partner for cDNA products has 
been described [13, 14, 22], the pJuFo technology which 
uses the pIII-Jun-Fos-cDNA fusion is well established for 
the efficient selection and identification of protein-protein 
interacting partners [16]. To determine if these proteins are 
displayed in a native-like conformation, we have generated 
phagemid vectors displaying E. coli PhoA on the surface of 
filamentous phage particles as pIII or pVIII fusion proteins 
via the Jun-Fos linker, determined the kinetic parameters of 
the phagemid-displayed enzymes and compared them to 
those of soluble PhoA. It has been shown previously that 
functional PhoA can be displayed on the surface of filamen-
tous phage [11, 14, 15, 23]. However, only McCafferty et al. 
[23] provide detailed kinetic data and show that PhoA di-
rectly fused to the N-terminus of pIII exhibits a different Km 
compared to soluble PhoA. 
  As shown in Table 1 PhoA displayed on pJuFo –III 
phagemids exhibits a Km of 11.2 M, which is in agreement 
with published data of soluble PhoA [23, 24]. This value is 
independent from PhoA being displayed as pIII or pVIII 
fusion and independent of the IPTG concentration under 
which the nascent PhoA-phagemid is being produced.  
Table 1.  Michaelis Constants of Different Phagemid Prepara-
tions and of Soluble PhoA 
Sample c(IPTG)  [M]  Km [M]
d) 
pIII-PhoA 0  11.2  (+ 0.1) 
pIII-PhoA 1  12.3  (+ 0.9 ) 
pIII-PhoA 10  9.0  (+ 0.8 ) 
pIII-PhoA 100 9.8  (+ 1.1 ) 
pIII-PhoA 1000  10.1  (+ 1.2 ) 
pVIII-PhoA 0 12.9  (+ 1.0 ) 
pVIII-PhoA 1 12.9  (+ 1.2 ) 
pVIII-PhoA 10 12.3  (+ 0.9) 
pVIII-PhoA 100 11.0  (+ 0.7) 
pVIII-PhoA 1000 11.0  (+ 0.6) 
PhoA
 a)   12.3  (+ 0.2) 
PhoA
b)   12.7 
PhoA
c)   8.5 
a)Km from the present work, 
b)Km from [24], 
c)Km from [23]. 
d)The standard deviation 
derived from three experiments performed with independent freshly prepared 
phagemids is given in parentheses.  
 
  Assuming that the individual rate constants composing 
Km of PhoA-phagemid are comparable to those of soluble 
PhoA the number of active enzyme molecules displayed on 
each phagemid particle can be calculated. Fig. (2) shows the 
molar activities of wtPhoA, PhoA-pIII-phagemid and PhoA-
pVIII-phagemid produced in the absence of IPTG. Under 
this condition PhoA is presented nearly twice as effectively 
via  pIII than via  pVIII. However, PhoA-pIII-phagemid 
shows a molar activity of 1587 mol substrate/mol phage/min 
compared to a molar activity of 3539 mol substrate/mol en-
zyme/min for soluble PhoA, indicating that only 45% of the 
phagemids display one active enzyme molecule via pIII. 
  Another aim of this study was to investigate if and to 
what extend addition of IPTG during phagemid production 
would increase the decoration of phagemids with active en-
zyme. We therefore tested in a first step the inducibility of 
the pJuFo::phoA vectors by preparing periplasmic fractions 
from phagemid producing XL1-Blue cultures grown with or 
without 1 mM IPTG. The periplasmic fractions were then 
subjected to Western blot analysis and the Fos-PhoA fusion 
protein was detected by HRP-labelled anti-bacterial PhoA 
mAb 7319. As shown in Fig. (3), induction of fos::phoA 
expression is enhanced with IPTG in either of the phagemid 
vectors during the entire period of phage propagation. Sur-
prisingly, the difference in fos::phoA expression with and 
without IPTG is much less pronounced in pJuFoIII::phoA 
(Fig. 3A) compared to pJuFoVIII::phoA (Fig. 3B). This dif-
ference might be more obvious if we consider that the perip-Display of E. coli Alkaline Phosphatase pIII or pVIII Fusions  The Open Biochemistry Journal, 2008, Volume 2    41 
lasmic extracts of the cultures grown in medium with 1 mM 
IPTG were prepared from a 10 to 15% reduced cell number 
compared to those grown without IPTG (Fig. 3C). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Michaelis-Menten plot of soluble PhoA (solid black cir-
cles), PhoA-pIII-phagemid (light grey squares) and PhoA-pVIII-
phagemid (dark grey diamonds). Molar activities are plotted against 
the substrate concentration to calculate the kinetic parameters 
summarized in Table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Western blot analysis of periplasmic extracts directly be-
fore,  h, 1 h, 2 h, 4 h and 10 h after helper phage superinfection, 
and of soluble wtPhoA (left lane). (A) Fos-PhoA detected in XL1-
Blue harbouring pJuFoIII::phoA without (-) and in the presence of 
1 mM IPTG (+). (B) Fos-PhoA detected in XL1-Blue harbouring 
pJuFoVIII::phoA grown without (-) and in the presence of 1 mM 
IPTG (+). (C) Growth rate of XL1-blue/pJuFoIII::phoA (squares) 
and XL1-blue/pJuFoVIII::phoA (circles) grown without (open sym-
bols) and with 1 mM IPTG (solid symbols). 
  To directly investigate the effect of the inducer on the 
valency of PhoA-phagemids we then added IPTG to final 
concentrations of 1 M, 10 M, 100 M and 1000 M 30 
min after 10 M, 100 M and 1000 M 30 min after infect-
ing the bacteria with helper phage and prepared the 
phagemids after another 9 h. The molar activities of these 
PhoA-phagemids are shown in Fig. (4). We observed a two-
fold increase of PhoA-pVIII-phagemid activity in the range 
between 1 M and 10 M IPTG with an apparent activity 
saturation at IPTG concentrations higher than 10 M. An 
increase in molar activity could also be detected in the case 
of PhoA-pIII-phagemids at IPTG concentrations  10 M, 
but it was much less pronounced. Because both jun::gIII and 
fos::phoA are under control of lacZ promotors, we consider 
this behaviour to reflect the in vivo dissociation constant of 
inducer and Lac repressor, which is 5.7 M [25]. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Molar activities of soluble dimeric PhoA (black), PhoA-
pIII-phagemid (light grey) and PhoA-pVIII-phagemid (dark grey) 
in dependence on the IPTG concentration. Molar activities of 
PhoA-phagemid are measured per phage particle. As control pIII-
pJuFo and pVIII-pJuFo phagemids without a PhoA fusion were 
used. The molar activities of these control samples were 1.33 and 
1.99 mol substrate converted/mol phage/min respectively (small 
figure top left). 
 
  The finding that a maximum of one copy of PhoA is dis-
played on either species of pJuFo phagemids could also be 
confirmed by Western blot analysis (Fig. 5).  
 
 
 
 
 
Fig. (5).  Western blot analysis of 10
12 phage particles (quantified 
by A260 measurements) prepared 10 h after helper phage infection 
and detection by polyclonal anti-PhoA rabbit antibody ab7319. 
Lane 1: 7.81·10
-5 mg wtPhoA (= 10
12 PhoA subunits). Lane 2: 
PhoA-pIII-phagemid amplified without IPTG. Lane 3: PhoA-pIII-
phagemid amplified in the presence of 1 mM IPTG. Lane 4: PhoA-
pVIII-phagemid amplified without IPTG. Lane 3: PhoA-pVIII-
phagemid amplified in the presence of 1 mM IPTG. 
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  However, it should be annotated that both total phagemid 
yield as well as their infectivity decrease with increasing 
IPTG concentration as shown in Fig. (6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Phage yields (solid bars), and infectivities (diagonals) of 
PhoA-pIII-phagemid (light grey) and PhoA-pVIII-phagemid (dark 
grey) preparations in the absence and presence of IPTG during 
phage production. 100% represent 4·10
13 phagemids/ml (PhoA-
pIII-phagemid) and 9·10
13 phagemids/ml (PhoA-pIII-phagemid) 
respectively. Infectivity is measured in transforming units per ml. 
 
  The titer of PhoA-pIII-phagemids produced at IPTG con-
centrations  10 M was less than 50 % compared to the 
phagemid titers obtained without induction, while infectivity 
decreased almost twofold from 1.8 to 1.0 percent. For PhoA-
pVIII-phagemids the total yield even dropped below 30 % at 
IPTG concentrations  10 M, while infectivity decreased 
from 5.5 (no IPTG) to 3.3 percent (1000 M IPTG) and thus 
was always higher compared to the pIII fusion. However, 
infectivity of PhoA-pVIII-phagemids decreased significantly 
after 48 h storage at 4°C, indicating that the phage displaying 
the PhoA-pVIII fusion protein is less stable than the phage 
displaying the PhoA-pIII fusion protein (data not shown). 
Therefore we recommend the use of pIII as a fusion partner 
for phage surface display of cDNA libraries. 
DISCUSSION  
  Success and failure of phage display methods critically 
depend on distinct experimental variables and parameters, as 
was indicated on the basis of stochastic models [26]. Besides 
the effective concentration of immobilized high affinity 
ligands and the stringency of washing steps, particularly 
complexity and titer of a phage library as well as valency of 
phage have an impact on the outcoming of a biopanning-
based selection experiment. In order to investigate valency, 
infectivity and display quality of the pJuFo phagemid, which 
has proven a versatile vector for the screening of cDNA li-
braries of various allergic sources [18], human tumor cells 
[19], mice B cells [27], and human fibroblasts [20], we gen-
erated pJuFo-PhoA phagemids in which PhoA was either 
fused to the minor coat protein pIII or to the major coat pro-
tein pVIII via a Jun-Fos linker. PhoA is a homodimeric pro-
tein located in the periplasm of E. coli and has a molar mass 
of 47 kDa per subunit [28]. There is strong evidence from 
the literature that only dimeric PhoA is catalytically active 
[29, 30]. Therefore, it was surprising that the Michaelis con-
stant Km of the phage-displayed PhoA was identical to that of 
soluble PhoA (Table 1), indicating that dimeric proteins can 
be displayed in a native-like fashion on the surface of pJuFo 
phagemids and that the two intramolecular disulfide bonds 
present in the PhoA subunit are formed correctly. Further-
more, we may conclude that the individual rate constants 
composing Km in the PhoA-phagemids are identical to those 
of soluble PhoA. Thus, kcat or molar activities of PhoA-
phagemids and soluble PhoA may be compared directly to 
calculate the valency of PhoA-phagemids. 
  As shown in Fig. (4) all of the PhoA-phagemid popula-
tions prepared from incubations with or without IPTG dis-
play lower activity than the soluble PhoA indicating that 
statistically maximally one of the five [31] copies of pIII and 
one of 2700 copies of pVIII represents a PhoA-coat protein 
fusion. This observation is supported by Western blot analy-
sis (Fig. 5), and thus we may conclude that the majority of 
the displayed PhoA fusion molecules are also enzymatically 
active. 
  It has been shown earlier that the decoration of filamen-
tous hybrid phage with peptides fused to pVIII critically de-
pends on the length of the peptide [32-34] and, even more, 
on the rate of processing of the molar pro-coat fusion protein 
[35] which is a critical step in recombinant phage assembly. 
As a result the infectivity of phage populations that display a 
10 or 16 amino acid peptide drops from 20% to 1% [34], 
respectively. Malik et al. [40] have impressively demon-
strated by Western blot analysis that 12mers and 16mers can 
be displayed in up to 40% and 25% of the pVIII copies, re-
spectively. According to their model-building approach the 
phage coat could even be decorated with a folded 100 kDa 
protein at a saturation of 24% [35]. However, experiments in 
which the display of a scFv via pIII and pVIII was directly 
compared by ELISA clearly showed that pIII was more effi-
cient than pVIII in displaying coat fusion proteins even 
though there are much less copies of pIII present in a phage 
particle [36]. Those results generally corroborate our find-
ings that the display of PhoA via pIII is more efficient than 
via  pVIII when the PhoA-coat protein fusion is produced 
from a phagemid vector in the absence of induction (Fig. 2). 
But so far there is no hint in the literature why the copy 
number of displayed PhoA should be restricted to one per 
phage particle, even when fused to the major coat protein 
pVIII. 
  When produced in the presence of IPTG as strong in-
ducer of the lacZ promoter, the titer of PhoA-pVIII-
phagemids was always lower compared to PhoA-pIII-
phagemids. However, the infectivity of the PhoA-pVIII-
phagemid remained higher than that of the PhoA-pIII-
phagemid. 
  Taken into account that the complexity of a primary 
cDNA library is usually in the range of 10
7 primary clones 
and that the amplified phagemid populations from all ex-
periments exceeded a titer of 1·10
11 transforming units per 
ml (tu/ml) it remains irrelevant whether the cDNA products 
are displayed via pIII or pVIII. In any case the cDNA library 
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will be entirely displayed on the phage surface and makes 
pJuFo an ideal phagemid vector for the screening of cDNA 
libraries from various origins.  
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